Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Insulin Degludec Versus Glargine U300 for the Management of Hospitalized Patients With Type 2 Diabetes: Randomized Controlled Trial

NCT05036876 is registered in ClinicalTrials.gov with Medanta, The Medicity, India as lead sponsor.

NCT NCT05036876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05036876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Insulin Degludec Versus Glargine U300 for the Management of Hospitalized Patients With Type 2 Diabetes: Randomized Controlled Trial
Lead sponsor
Medanta, The Medicity, India
Phase
Not applicable
Overall status
Completed
Start date
October 10, 2021
Completion date
March 1, 2022
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes